Seviteronel

N/A

Report date: 2024/01/02 20:03:52
NME

Base Information

Drug NameSeviteronel
Drug Alias Name司维特奈seviteronel赛维罗奈seviteronelumVT-464
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor antagonists
TargetsAndrogen Receptor
Therapy Area/IndicationsMetastatic breast cancerProstatic Neoplasms, Castration-ResistantProstatic Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerlandUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesViamet Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnocrin Pharmaceutical
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancerProstatic Neoplasms, Castration-ResistantProstatic Neoplasms +[6] 

Other Information

ATC CodeN/A
Related LinksWikipedia